Dec 01, 2022 / 02:30PM GMT
Adam Maeder - Piper Sandler - Analyst
Good morning. Welcome to the 2022 Piper Sandler healthcare conference. My name is Adam Maeder. I'm one of the medtech research analysts here at Piper. Very pleased to introduce the management team from Neuronetics. With us, we have Keith Sullivan, the President and CEO; Steve Furlong, SVP, CFO, and Treasurer. Gentlemen, thanks so much for coming.
Keith Sullivan - Neuronetics, Inc. - President & CEO
Thanks, Adam.
Questions and Answers:
Adam Maeder - Piper Sandler - AnalystNice to see you. So maybe a good place to start is with the Q3 results. You're coming up a nice Q3 print, good performance both in terms of system placements and session volumes. You took up the full-year outlook. Maybe just spend some time on the expectations for 4Q. How do we think about the mix of capital and treatment sessions? And what's maybe assumed in some of the guidance for macro headwinds, et cetera?
Steve Furlong - Neuronetics, Inc. - SVP, CFO, & Treasurer<